How do we help patients?
We discover and deliver medicines that make a remarkable impact on patients right now.
“They're dedicating their lives and their science to making the world a better place. If I were to meet the AbbVie scientists, I would just hug them.”
18M people a year take AbbVie medicines in the U.S.
60 conditions treated by AbbVie medicines
- Rheumatoid arthritis
- Blood cancers
- Hepatitis C
- Parkinson’s disease
- Psoriasis
- Crohn’s disease
- Endometriosis
- Ulcerative colitis
- Hypothyroidism
- Psoriatic arthritis
- Juvenile idiopathic arthritis
- Endocrine pancreatic insufficiency
- Rheumatoid arthritis
- Blood cancers
- Hepatitis C
- Parkinson’s disease
- Psoriasis
- Crohn’s disease
- Endometriosis
- Chronic Migraine
- Glaucoma
- Schizophrenia
- Bipolar disorder
- Hypothyroidism
- Psoriatic arthritis
- Juvenile idiopathic arthritis
- Endocrine pancreatic insufficiency
- Rheumatoid arthritis
- Blood cancers
- Hepatitis C
- Parkinson’s disease
- Psoriasis
- Crohn’s disease
- Endometriosis
- Ulcerative colitis
- Hypothyroidism
- Psoriatic arthritis
- Juvenile idiopathic arthritis
- Endocrine pancreatic insufficiency
Patient Assistance Program
“I was able to use the AbbVie patient assistance program, which was a blessing.”
Patient Assistance Program
~155,000 U.S. patients received medicine at no cost in 2020 through myAbbVie Assist patient assistance program
What does it take to invent medicines of the future?
- Tenacious discoverers.
- Explorers.
- Problem solvers.
- Optimists.
These are just some of the tough diseases we’re tackling:
- Alzheimer’s disease
- Cancer
- Parkinson’s disease
- Multiple sclerosis
- Chronic Migraine
- Crohn’s disease
- Atopic dermatitis
- Uterine fibroids
- Rheumatoid arthritis
- Glaucoma
$5.8B invested in researching medicines in 2020, and approximately $50B since AbbVie’s launch in 2013 through 2020.
72% of medicines in our pipeline considered first-in-kind
You can’t do today’s job with yesterday’s methods and be successful tomorrow.
Innovating clinical trials
70K+ patients participating in AbbVie clinical trials in the U.S.
Advancements in technology are changing how we conduct clinical trials.
Using a range of new technologies, from artificial intelligence to wearables, we can improve the efficiency and speed of clinical trials, ultimately striving to bring treatments to patients more quickly.
70K+ patients participating in AbbVie clinical trials in the U.S.
